Medexus Pharmaceuticals Inc. (MEDXF)

Medexus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 17, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	59	29	24	50	120	25
Market Cap Growth	29.85%	21.85%	-52.44%	-58.30%	390.26%	-49.66%
Enterprise Value	92	72	80	94	162	27
Last Close Price	1.77	1.22	1.19	2.51	6.30	2.00
PE Ratio	16.66	-	19.55	-	-	-
PS Ratio	0.54	0.26	0.22	0.65	1.51	0.44
PB Ratio	1.79	0.96	1.06	2.82	6.68	1.01
P/FCF Ratio	2.55	1.56	-	-	24.45	-
P/OCF Ratio	2.54	1.55	-	-	23.88	-
EV/Sales Ratio	0.81	0.64	0.74	1.23	2.04	0.49
EV/EBITDA Ratio	4.20	3.91	5.59	-	25.52	11.14
EV/EBIT Ratio	5.90	5.64	9.46	-	221.81	-
EV/FCF Ratio	3.96	3.86	-	-	32.94	-
Debt / Equity Ratio	1.21	1.65	3.12	3.08	2.49	1.60
Debt / EBITDA Ratio	1.89	2.68	4.81	-	6.69	13.91
Debt / FCF Ratio	1.72	2.67	-	-	9.12	-
Asset Turnover	0.72	0.71	0.72	0.53	0.59	0.55
Inventory Turnover	1.50	1.79	1.92	1.83	2.24	2.31
Quick Ratio	0.34	0.44	0.43	0.51	0.94	0.59
Current Ratio	1.01	1.10	0.87	1.02	1.47	1.16
Return on Equity (ROE)	11.37%	-0.81%	6.07%	-16.08%	-133.66%	-18.55%
Return on Assets (ROA)	6.13%	5.04%	3.53%	-5.38%	0.34%	-0.70%
Return on Capital (ROIC)	12.14%	9.25%	6.42%	-11.41%	0.73%	-1.35%
Return on Capital Employed (ROCE)	18.90%	14.30%	10.90%	-	0.70%	-
Earnings Yield	600.32%	-0.74%	5.12%	-5.74%	-23.48%	-19.15%
FCF Yield	3915.59%	64.18%	-6.31%	-2.54%	4.09%	-7.36%
Buyback Yield / Dilution	-1360.40%	-9.56%	-3.36%	-30.65%	-5.83%	-44.92%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.